Vitamin Shoppe Inc (NYSE:VSI)’s share price shot up 6.2% during trading on Tuesday . The company traded as high as $7.88 and last traded at $7.84. 645,038 shares were traded during trading, an increase of 6% from the average session volume of 610,592 shares. The stock had previously closed at $7.38.
A number of brokerages have recently commented on VSI. ValuEngine raised shares of Vitamin Shoppe from a “hold” rating to a “buy” rating in a research report on Wednesday, August 8th. Barclays lowered shares of Vitamin Shoppe from an “equal weight” rating to an “underweight” rating in a research report on Friday, September 7th. Morgan Stanley began coverage on shares of Vitamin Shoppe in a research report on Monday, September 17th. They set an “equal weight” rating and a $14.00 target price on the stock. Finally, Zacks Investment Research lowered shares of Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Wednesday, October 17th.
The firm has a market cap of $188.33 million, a PE ratio of 20.10 and a beta of 0.94. The company has a current ratio of 1.96, a quick ratio of 0.32 and a debt-to-equity ratio of 0.32.
Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings data on Wednesday, August 8th. The specialty retailer reported $0.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.04 by $0.27. The company had revenue of $293.10 million for the quarter, compared to analyst estimates of $279.87 million. Vitamin Shoppe had a negative net margin of 8.76% and a positive return on equity of 2.42%. On average, analysts anticipate that Vitamin Shoppe Inc will post 0.13 EPS for the current fiscal year.
In other Vitamin Shoppe news, CEO Sharon M. Leite acquired 5,500 shares of the business’s stock in a transaction that occurred on Friday, August 31st. The shares were bought at an average cost of $12.64 per share, with a total value of $69,520.00. Following the completion of the acquisition, the chief executive officer now directly owns 5,500 shares in the company, valued at approximately $69,520. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Guillermo Marmol acquired 8,900 shares of the business’s stock in a transaction that occurred on Friday, August 10th. The shares were acquired at an average cost of $11.21 per share, for a total transaction of $99,769.00. Following the completion of the acquisition, the director now owns 49,479 shares of the company’s stock, valued at $554,659.59. The disclosure for this purchase can be found here. Company insiders own 18.50% of the company’s stock.
A number of hedge funds have recently modified their holdings of VSI. GMT Capital Corp acquired a new position in shares of Vitamin Shoppe in the second quarter worth about $7,991,000. WINTON GROUP Ltd acquired a new position in shares of Vitamin Shoppe in the third quarter worth about $6,581,000. FMR LLC raised its position in shares of Vitamin Shoppe by 49.7% in the second quarter. FMR LLC now owns 1,624,543 shares of the specialty retailer’s stock worth $11,290,000 after acquiring an additional 539,100 shares during the period. Millennium Management LLC acquired a new position in shares of Vitamin Shoppe in the first quarter worth about $1,628,000. Finally, Dimensional Fund Advisors LP raised its position in shares of Vitamin Shoppe by 10.4% in the first quarter. Dimensional Fund Advisors LP now owns 1,675,437 shares of the specialty retailer’s stock worth $7,288,000 after acquiring an additional 158,123 shares during the period. 89.24% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION NOTICE: This news story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/11/06/vitamin-shoppe-vsi-shares-up-6-2.html.
About Vitamin Shoppe (NYSE:VSI)
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Featured Story: How much money do you need to begin day trading?
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.